Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Theranos Closes Labs, Focuses On New Medical Device

XTALKS VITALS NEWS

Elizabeth Holmes

As a result of the closures, Theranos will be laying-off 340 workers across California, Pennsylvania and Arizona.

Tweetables from this article:

Tweet: #Theranos will be laying-off 340 workers across California, Pennsylvania and Arizona http://ctt.ec/7u5lk+ Theranos will be laying-off 340 workers across California, Pennsylvania and Arizona.

Share this!

October 7, 2016 | by Sarah Hand, M.Sc.

In a surprising turn, Theranos founder Elizabeth Holmes has announced the company will be shutting down clinical testing labs and consumer blood testing services, in order to focus on its recently-unveiled miniLab medical device. As a result of the closures, Theranos will be laying-off 340 workers across California, Pennsylvania and Arizona.

Theranos’ novel blood testing technology has been the basis of the business since the beginning, but has recently faced controversy after the company voided thousands of test results in response to concerns over the technology’s accuracy. Amidst the controversy, Holmes received a 2 year ban from owning a blood testing laboratory from the Centers for Medicare & Medicaid Services (CMS).



“We will return our undivided attention to our miniLab platform,” said Holmes in an open letter on Theranos’ website. “Our ultimate goal is to commercialize miniaturized, automated laboratories capable of small-volume sample testing, with an emphasis on vulnerable patient populations, including oncology, pediatrics, and intensive care.”

The letter also refers to a new executive team at Theranos, an announcement that follows COO and President Sunny Balwani’s decision to resign earlier this year. Holmes also vows to pursue FDA approval for the new device, along with publications in peer-reviewed journals. The company has previously faced scrutiny over failing to publish data from their Edison medical device.

Their next focus – the miniLab medical device – was announced in August at the American Association for Clinical Chemistry (AACC) conference. Holmes claims the device will be able to use multiple diagnostic methods to analyze a small-volume blood sample using a single device.

“We’re pleased to share our technologies with the entire laboratory industry,” Holmes said of the miniLab device. “It’s the beginning of the next phase of the company, as we introduce our technologies to the world. We also will be working with academic institutions and other independent parties to validate and publish our results.”


Keywords: Blood Testing, Medical Device, Clinical Laboratory


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Food Companies are Looking for the Next Sriracha

October 19, 2017 - The Sriracha trend might be coming to an end and companies are looking for the next big hot sauce star to feature in their line-up.

Featured In: Food News


CFIA Recalling Mechanically Tenderized Steaks in Canada for E. coli

October 19, 2017 - The Canadian Food Inspection Agency posted a recall for mechanically tenderized steaks at the request of Vantage Foods Inc. on Tuesday.

Featured In: Food News


Study: Gender May Be Important When Matching Blood Transfusion Recipients to Donors

October 19, 2017 - According to a new study published in JAMA, gender and a history of pregnancy among female donors may have an impact on how well blood donors and recipients can be matched.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Brexit – Separating Fact from Fiction


Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond


Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms


Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution


Copyright © 2016-2017 Honeycomb Worldwide Inc.